Latest Breaking News On - Kathy phlegar - Page 1 : comparemela.com

/PRNewswire/ GlycoPath Inc., developer of advanced bioanalytical assays based on its proprietary GlycoTyper™ immunoaffinity technology, has appointed Kathy.

Kathy phlegarRichard drakeDanielle scottZucker institute for innovation commercializationUniversity of south carolinaGlycopath incMedical universitySouth carolina